- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Financially Fit Penny Stocks
Hong Kong Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
18
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
18 companies
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$1.97
7D
13.2%
1Y
111.8%
Pak Fah Yeow International
Market Cap: HK$707.4m
An investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.27
7D
1.8%
1Y
10.2%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.13
7D
-5.0%
1Y
-5.8%
SSY Group
Market Cap: HK$9.0b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.04
7D
-10.6%
1Y
-38.0%
Uni-Bio Science Group
Market Cap: HK$400.1m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.067
7D
-2.9%
1Y
-22.1%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$941.2m
Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$1.68
7D
0%
1Y
-4.0%
Lee's Pharmaceutical Holdings
Market Cap: HK$718.4m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
950
HK$1.22
7D
-12.9%
1Y
3.4%
JW (Cayman) Therapeutics
Market Cap: HK$598.8m
A clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China.
2126
HK$1.48
7D
-9.2%
1Y
-17.3%
Frontage Holdings
Market Cap: HK$2.4b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.18
7D
-5.6%
1Y
-12.6%
China Regenerative Medicine International
Market Cap: HK$88.2m
An investment holding company, engages in the provision of healthcare products and services in Hong Kong and the People’s Republic of China.
8158
HK$0.29
7D
-7.9%
1Y
3.6%
Tong Ren Tang Technologies
Market Cap: HK$6.0b
Manufactures and sells Chinese medicine products in Mainland China and internationally.
1666
HK$4.65
7D
-4.5%
1Y
-7.9%
China Health Group
Market Cap: HK$141.3m
An investment holding company, provides research and development services of drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.
8225
HK$0.14
7D
-20.7%
1Y
30.3%
Ocumension Therapeutics
Market Cap: HK$3.9b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$4.77
7D
-8.1%
1Y
-19.0%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$6.5b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$2.32
7D
-10.4%
1Y
10.0%
Antengene
Market Cap: HK$1.8b
A biopharmaceutical company, engages in the development of novel oncology therapies in Greater China and internationally.
6996
HK$2.67
7D
-17.8%
1Y
181.1%
Brii Biosciences
Market Cap: HK$1.2b
Engages in the research and development of therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$1.62
7D
-16.1%
1Y
67.0%
Jacobio Pharmaceuticals Group
Market Cap: HK$2.4b
An investment holding company, engages in the in-house discovery and development of oncology therapies.
1167
HK$3.07
7D
-17.3%
1Y
88.3%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$5.8b
An investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$0.63
7D
-4.5%
1Y
21.2%